Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on May 20, 2025
Amerigo Scientific Introduces Electrospun Polycaprolactone Scaffolds for 3D Cell Culture
EIN Presswire
·
May 20, 2025
Amerigo Scientific has unveiled its 3D electrospun polycaprolactone (PCL) scaffolds tailored for 3D cell culture applications. NEW YORK, NY, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Amerigo Scientific has unveiled its 3D electrospun …
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 20, 2025
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …
INVO Fertility Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 20, 2025
SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Tactile Medical to Present at Upcoming Investor Conferences in June
GlobeNewswire
·
May 20, 2025
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be …
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with…
GlobeNewswire
·
May 20, 2025
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced data presented from its clinical development …
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
GlobeNewswire
·
May 20, 2025
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening Skin Cancer Awareness Month in May shines a spotlight on the growing burden of advanced skin cancers …
Avalyn Showcases Clinical Data Across Multiple Pulmonary Fibrosis Programs at ATS 2025
GlobeNewswire
·
May 20, 2025
Topline results for AP02 (inhaled nintedanib) confirmed safety and tolerability with limited systemic exposure and substantially improved lung exposure compared to oral nintedanib AP01 (inhaled pirfenidone) treatment demonstrated long-term antifibrotic …
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody
GlobeNewswire
·
May 20, 2025
Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in 1H 2026 ORKA-002 preclinical data demonstrate the potential for dosing two to three times per year in psoriasis, a significant …
Alameda Health System expands stroke care with Wilma Chan Highland Hospital Campus’ new certification
GlobeNewswire
·
May 20, 2025
OAKLAND, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) patients experiencing the sudden and frightening symptoms of a stroke will now receive faster and more-integrated care, thanks to the Wilma Chan Highland Hospital Campus’ (WCHHC) …
Scientific Papers Detail How Human Brains Contain a 'Spoonful of Plastic' Linked to Ultra-Processed Foods
EIN Presswire
·
May 20, 2025
Articles in Brain Medicine show microplastics from ultra-processed foods accumulate in the brain, potentially contributing to depression, anxiety, and dementia NEW YORK, NY, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- A remarkable collection of …
Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
GlobeNewswire
·
May 20, 2025
New York, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising …
America's Blood Centers Releases New Report Showing the Critical Role of Community Blood Centers in Expanding Prehospital Blood Programs
GlobeNewswire
·
May 20, 2025
Washington, DC, May 20, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today released its latest report, "A Vital Resource …
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
GlobeNewswire
·
May 20, 2025
ZURICH, May 20, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today the appointment of …
Santheras Aktionäre stimmen an der heutigen Generalversammlung allen Anträgen des Verwaltungsrats zu
GlobeNewswire
·
May 20, 2025
Pratteln, Schweiz, 20. Mai 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass die Aktionäre an der heutigen Generalversammlung (GV) in Pratteln, Schweiz, allen Anträgen des Verwaltungsrates mit grosser Mehrheit zugestimmt haben. Die …
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
GlobeNewswire
·
May 20, 2025
Pratteln, Switzerland, May 20, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland, with a large majority. …
Sierra Tucson Receives National Fraternal Order of Police Recognition
GlobeNewswire
·
May 20, 2025
TUCSON, Ariz., May 20, 2025 (GLOBE NEWSWIRE) -- Sierra Tucson, one of the country’s leading behavioral health treatment centers, announced that its Red, White and Blue program has been officially recognized and approved by the National Fraternal Order of …
Stroke Awareness Month: Neurosurgeon Dr. Kendrick Johnson Discusses Stroke Symptoms and Treatments with YourUpdateTV
GlobeNewswire
·
May 20, 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Stroke can happen anytime, anywhere and to anyone. In the US, there are approximately 800,000 strokes a year, among people of all ages. May is Stroke Awareness Month, and recently, Dr. Kendrick Johnson, …
AscellaHealth to Present on Site of Care Strategies for High-Cost Medications at SIIA Stakeholder Forum
GlobeNewswire
·
May 20, 2025
BERWYN, Pa., May 20, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, is excited to announce its participation in the Self-Insurance Institute of America’s (SIIA) …
Founder of Pfeifer Aesthetic Plastic Surgery Appointed President of The Aesthetic Society
GlobeNewswire
·
May 20, 2025
New York, NY, May 20, 2025 (GLOBE NEWSWIRE) -- Pfeifer Aesthetic Plastic Surgery proudly announces that its founder, Dr. Tracy M. Pfeifer, has been appointed as the 2025 President of The American Society for Aesthetic Plastic Surgery (The Aesthetic Society …
PTPN Celebrates 40 Years of Empowering Private Practice Therapists Nationwide
GlobeNewswire
·
May 20, 2025
LOUISVILLE, Ky., May 20, 2025 (GLOBE NEWSWIRE) -- PTPN, the nation's first specialty network for rehabilitation therapists, and member of the Confluent Health family, is celebrating its 40th anniversary, marking four decades of innovation and unwavering …